Development of MR quantified pancreatic fat deposition as a cancer risk biomarker

Both CS-MR and MRS (after accounting for pancreatic 3D dimensionality) were 'fit for purpose' to determine PFF and might add information on cancer prediction independent from measures of general body adiposity.